Skip to content

Released Feb 10, 2021, after the close

10-K filed Feb 19, 2021, 50 days after period end · 0001653477-21-000017

Q4 2020 · 10-K
Revenue$325.60M+7.3% vs Q4 2019−1.8% vs Q3 2020
Net Income$46.00M+3.8% vs Q4 2019−34.2% vs Q3 2020
EPS Diluted$1.11+5.7% vs Q4 2019−34.3% vs Q3 2020
Gross Profit$127,400,000+14.8%
Operating Incomederived$110,900,000+21.7%
Operating Cash Flowderived$153,300,000+79.3%
Free Cash Flowderived$122,200,000+142.0%
Margins · derived
Gross margin39.1%+2.5 pt vs Q4 2019
Operating margin34.1%+4.0 pt vs Q4 2019
Net margin14.1%−0.5 pt vs Q4 2019

What the release said

The release

Same quarter

MetricQ4 2020Q4 2019Q4 2018Q4 2017
Revenue$325.60M$303.40M$278.60M$229.50M
Net Income$46.00M$44.30M$42.10M$41.60M
EPS Diluted$1.11$1.05$0.99$0.97

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR